Literature DB >> 24316660

Characterizing focal hepatic lesions by free-breathing intravoxel incoherent motion MRI at 3.0 T.

Haruo Watanabe1, Masayuki Kanematsu2, Satoshi Goshima3, Kimihiro Kajita4, Hiroshi Kawada3, Yoshifumi Noda3, Yukichi Tatahashi3, Nobuyuki Kawai3, Hiroshi Kondo3, Noriyuki Moriyama5.   

Abstract

BACKGROUND: Diffusion-weighted (DW) imaging is commonly used to distinguish between benign and malignant liver lesions.
PURPOSE: To prospectively evaluate the true molecular-diffusion coefficient (D), perfusion-related diffusion coefficient (D*), perfusion fraction (f), and ADC of focal hepatic lesions using a free-breathing intravoxel incoherent motion (IVIM) DW sequence, and to determine if these parameters are useful for characterizing focal hepatic lesions.
MATERIAL AND METHODS: One hundred and twenty hepatic lesions (34 metastases, 32 hepatocellular carcinoma [HCC], 33 hemangiomas, and 21 liver cysts) in 74 patients were examined. Mean D, D*, f, and ADC values of hepatic lesions were compared among pathologies. ROC curve analyses were performed to assess the performances of D, D*, f, and ADC values for the characterization of liver lesions as benign or malignant.
RESULTS: The mean D and ADC values of benign lesions were greater than those of malignant lesions (P < 0.001). Although the mean D and ADC values of liver cysts were greater than those of hemangiomas (P < 0.001), and these values were not significantly different between metastases and HCCs (P = 0.99). Area under the ROC curve for ADC values (0.98) was significantly greater (P = 0.048) than that for D values (0.96) for the differentiation of benign and malignant lesions. Sensitivity and specificity for the detection of malignant lesion were 89% and 98%, respectively, when an ADC cut-off value of 1.40 was applied.
CONCLUSION: D and ADC values have more potential for characterizing focal hepatic lesions than D* or f values, and for the differentiation of malignancy and benignity. © The Foundation Acta Radiologica 2013 Reprints and permissions: sagepub.co.uk/journalsPermissions.nav.

Entities:  

Keywords:  Hepatic nodule; Intravoxel incoherent motion; diffusion

Mesh:

Substances:

Year:  2013        PMID: 24316660     DOI: 10.1177/0284185113514966

Source DB:  PubMed          Journal:  Acta Radiol        ISSN: 0284-1851            Impact factor:   1.990


  16 in total

1.  Intravoxel incoherent motion diffusion-weighted imaging of hepatocellular carcinoma: Is there a correlation with flow and perfusion metrics obtained with dynamic contrast-enhanced MRI?

Authors:  Stefanie J Hectors; Mathilde Wagner; Cecilia Besa; Octavia Bane; Hadrien A Dyvorne; M Isabel Fiel; Hongfa Zhu; Michael Donovan; Bachir Taouli
Journal:  J Magn Reson Imaging       Date:  2016-02-26       Impact factor: 4.813

Review 2.  Radiological Response to the Locoregional Treatment in Hepatocellular Carcinoma: RECIST, mRECIST, and Others.

Authors:  Mecit Kantarci; Berhan Pirimoglu
Journal:  J Gastrointest Cancer       Date:  2017-09

Review 3.  Functional imaging of hepatocellular carcinoma.

Authors:  Tim Ch Hoogenboom; Mark Thursz; Eric O Aboagye; Rohini Sharma
Journal:  Hepat Oncol       Date:  2016-03-29

4.  Intravoxel incoherent motion: application in differentiation of hepatocellular carcinoma and focal nodular hyperplasia.

Authors:  Ma Luo; Ling Zhang; Xin Hua Jiang; Wei Dong Zhang
Journal:  Diagn Interv Radiol       Date:  2017 Jul-Aug       Impact factor: 2.630

5.  Accurate IVIM model-based liver lesion characterisation can be achieved with only three b-value DWI.

Authors:  P Mürtz; A M Sprinkart; M Reick; C C Pieper; A-H Schievelkamp; R König; H H Schild; W A Willinek; G M Kukuk
Journal:  Eur Radiol       Date:  2018-04-18       Impact factor: 5.315

6.  Intravoxel incoherent motion and dynamic contrast-enhanced MRI for differentiation between hepatocellular adenoma and focal nodular hyperplasia.

Authors:  Naim Jerjir; Luk Bruyneel; Marc Haspeslagh; Sarah Quenet; Kenneth Coenegrachts
Journal:  Br J Radiol       Date:  2017-06-07       Impact factor: 3.039

Review 7.  Advanced imaging techniques in the therapeutic response of transarterial chemoembolization for hepatocellular carcinoma.

Authors:  Ke Yang; Xiao-Ming Zhang; Lin Yang; Hao Xu; Juan Peng
Journal:  World J Gastroenterol       Date:  2016-05-28       Impact factor: 5.742

Review 8.  Quantitative magnetic resonance imaging for focal liver lesions: bridging the gap between research and clinical practice.

Authors:  Roberto Cannella; Riccardo Sartoris; Jules Grégory; Lorenzo Garzelli; Valérie Vilgrain; Maxime Ronot; Marco Dioguardi Burgio
Journal:  Br J Radiol       Date:  2021-05-14       Impact factor: 3.629

9.  Could ADC values be a promising diagnostic criterion for differentiating malignant and benign hepatic lesions in Asian populations: A meta-analysis.

Authors:  Jing Peng; Jing-Jin Li; Jiang Li; He-Wen Li; Guo-Ping Xu; Rong-Rong Jia; Xue-Ning Zhang; Yang Zhao
Journal:  Medicine (Baltimore)       Date:  2016-11       Impact factor: 1.889

10.  Hepatocellular carcinoma: IVIM diffusion quantification for prediction of tumor necrosis compared to enhancement ratios.

Authors:  Suguru Kakite; Hadrien A Dyvorne; Karen M Lee; Guido H Jajamovich; Ashley Knight-Greenfield; Bachir Taouli
Journal:  Eur J Radiol Open       Date:  2015-12-08
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.